These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11791689)

  • 81. Systemic bioavailability of inhaled corticosteroids: appropriate and comparable methodology.
    Affrime MB; Banfield C; Nolop K
    Eur Respir J; 2001 Jul; 18(1):246. PubMed ID: 11510799
    [No Abstract]   [Full Text] [Related]  

  • 82. A comparison of the performance of two modern multidose dry powder asthma inhalers.
    Hill LS; Slater AL
    Respir Med; 1998 Jan; 92(1):105-10. PubMed ID: 9519233
    [TBL] [Abstract][Full Text] [Related]  

  • 83. In vitro and in vivo dose delivery characteristics of large porous particles for inhalation.
    Dunbar C; Scheuch G; Sommerer K; DeLong M; Verma A; Batycky R
    Int J Pharm; 2002 Oct; 245(1-2):179-89. PubMed ID: 12270254
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Optical diagnostics study of air flow and powder fluidisation in Nexthaler®--Part I: Studies with lactose placebo formulation.
    Pasquali I; Merusi C; Brambilla G; Long EJ; Hargrave GK; Versteeg HK
    Int J Pharm; 2015 Dec; 496(2):780-91. PubMed ID: 26545309
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Effects of mometasone furoate on human keratinocytes and fibroblasts in vitro.
    Wach F; Bosserhoff A; Kurzidym U; Nowok K; Landthaler M; Hein R
    Skin Pharmacol Appl Skin Physiol; 1998; 11(1):43-51. PubMed ID: 9603668
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Inhibition of elicitation of contact dermatitis in humans by mometasone furoate: evaluation by means of 20-MHz B scanning associated with image analysis.
    Di Nardo A; Giusti G; Mantovani L; Bianchi B; Seidenari S
    Dermatology; 1997; 195(2):137-41. PubMed ID: 9310720
    [TBL] [Abstract][Full Text] [Related]  

  • 87. High-performance liquid chromatographic analysis of mometasone furoate and its degradation products: application to in vitro degradation studies.
    Teng XW; Foe K; Brown KF; Cutler DJ; Davies NM
    J Pharm Biomed Anal; 2001 Sep; 26(2):313-9. PubMed ID: 11470208
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Review of the TAIFUN multidose dry powder inhaler technology.
    Overhoff KA; Clayborough R; Crowley M
    Drug Dev Ind Pharm; 2008 Sep; 34(9):960-5. PubMed ID: 18686086
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Oral mometasone furoate administration preserves anti-inflammatory action with fewer metabolic adverse effects in rats.
    Zimath PL; Almeida MS; Bruxel MA; Rafacho A
    Biochem Pharmacol; 2023 Apr; 210():115486. PubMed ID: 36893817
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Topical therapy with fluorinated and non-fluorinated corticosteroids in patients with atopic dermatitis.
    Gregurek-Novak T
    J Eur Acad Dermatol Venereol; 2001 Jan; 15(1):81-2. PubMed ID: 11451336
    [No Abstract]   [Full Text] [Related]  

  • 91. Inertial sizing of aerosol inhaled from two dry powder inhalers with realistic breath patterns versus constant flow rates.
    Finlay WH; Gehmlich MG
    Int J Pharm; 2000 Dec; 210(1-2):83-95. PubMed ID: 11163990
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Cascade impactor practice for a high dose dry powder inhaler at 90 L/min: NGI versus modified 6-stage and 8-stage ACI.
    Kamiya A; Sakagami M; Byron PR
    J Pharm Sci; 2009 Mar; 98(3):1028-39. PubMed ID: 18661538
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Pharmacokinetic Evidence of Steady and Sustained Drug Release from Long-Acting Implantable Corticosteroid Matrices for Chronic Rhinosinusitis.
    Ow RA; Shotts S; Kakarlapudi V; McIntyre J; Naclerio RM; You C; Pappas A; Brayton L; Kuang Y; Shao J
    Am J Rhinol Allergy; 2022 Nov; 36(6):733-740. PubMed ID: 35708181
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Comparison of cosmetic and physicochemical properties of six topical corticosteroid creams.
    Hadzija BW; Ambrose WW
    Cutis; 1996 Feb; 57(2 Suppl):13-8. PubMed ID: 8646864
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Binding affinities of mometasone furoate and related compounds including its metabolites for the glucocorticoid receptor of rat skin tissue.
    Isogai M; Shimizu H; Esumi Y; Terasawa T; Okada T; Sugeno K
    J Steroid Biochem Mol Biol; 1993 Feb; 44(2):141-5. PubMed ID: 8439518
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Human receptor kinetics, tissue binding affinity, and stability of mometasone furoate.
    Valotis A; Neukam K; Elert O; Högger P
    J Pharm Sci; 2004 May; 93(5):1337-50. PubMed ID: 15067709
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Preclinical Experimental and Mathematical Approaches for Assessing Effective Doses of Inhaled Drugs, Using Mometasone to Support Human Dose Predictions.
    Caniga M; Cabal A; Mehta K; Ross DS; Gil MA; Woodhouse JD; Eckman J; Naber JR; Callahan MK; Goncalves L; Hill SE; Mcleod RL; McIntosh F; Freke MC; Visser SA; Johnson N; Salmon M; Cicmil M
    J Aerosol Med Pulm Drug Deliv; 2016 Aug; 29(4):362-77. PubMed ID: 26859446
    [TBL] [Abstract][Full Text] [Related]  

  • 98. An unusual rearrangement product formed during production of mometasone furoate (Sch 32088).
    Puar MS; Thompson PA; Ruggeri M; Beiner D; McPhail AT
    Steroids; 1995 Sep; 60(9):612-4. PubMed ID: 8545849
    [TBL] [Abstract][Full Text] [Related]  

  • 99. A Proof-of-Principle Setup for Delivery of Relenza
    Leung SSY; Parumasivam T; Tang P; Chan HK
    J Aerosol Med Pulm Drug Deliv; 2016 Feb; 29(1):30-35. PubMed ID: 25974393
    [TBL] [Abstract][Full Text] [Related]  

  • 100. [Therapeutic recommendation in acute suppurative sinusitis. Antibiotic plus topical steroid].
    MMW Fortschr Med; 2001 Dec; 143(49-50):57. PubMed ID: 11808458
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.